Phoenix atherectomy system Hybrid atherectomy system

Phoenix atherectomy system

Hybrid atherectomy system

Find similar products

The Phoenix atherectomy system combines the benefits of existing atherectomy systems to deliver a unique, hybrid atherectomy option to help physicians tailor the treatment approach for each patient.¹ It cuts, captures, and clears diseased tissue with one insertion. Phoenix treats a broad range of tissue types, from soft plaque to calcified arteries, and can be used for lesions above and below the knee.²

Front cutter || KBA1

Front cutter

Front cutter clears tissue in a way that may help reduce potential trauma to the vessel.³
Capture and clearance || KBA1

Capture and clearance

Continuous capture and passive clearance of debulked material into the catheter resulted in a <1% rate of symptomatic distal emboli in the EASE trial.⁴
Ease of use || KBA1

Ease of use

Phoenix is battery-powered and handle-operated. No capital equipment or additional procedural accessories are required.
Deliverability || KBA1


Low-profile, front-cutting design allows for direct lesion access without having to first pass a nosecone. The over-the-wire design aids in trackability and pushability of catheter.
Versatility || KBA1


EASE trial data confirms the ability of Phoenix to effectively treat a broad range of tissue types, from soft plaque to calcified arteries, for lesions both above and below the knee.³,⁴ The 1.8 and 2.2 mm tracking catheters are suitable for treating small vessels or highly stenosed lesions. The 2.4 mm deflecting catheter is suitable for larger vessels or eccentric lesions.
  • 1. Hybrid atherectomy refers to the Phoenix family of products. 2.4mm deflecting catheter is the only device with directional cutting ability.
  • 2. Monitor flow of excised material into the disposal reservoir during operation of the Catheter. If flow of excised material ceases during the procedure, this is a sign that the Catheter drive system (cutter, torque shaft, or Handle motor drive) may not be operating properly.
  • 3. Phoenix atherectomy device is indicated for vessels 2.5mm in diameter and above.
  • 4. Endovascular Atherectomy Safety and Effectiveness Study (EASE), Identifier NCT01541774 (accessed 23Oct2015). Results presented at the Vascular Interventional Advances (VIVA) Conference in October of 2013 (Las Vegas, NV) by Stephen Williams, MD.
  • 5. Case study results are not predictive. Results in other cases may vary.
  • 6. Case performed by Dr. Christopher LeSar at the Vascular Institute of Chattanooga.
  • 7. Case performed by Dr. Joseph Griffin at Baton Rouge General Hospital.
  • 8. Center mass cutting device when the guidewire is centered.
  • 9. Case performed by Dr. William Crowder in Jackson, Mississippi.
  • 10. Case performed by Dr. Tom Davis in Detroit, MI.